Insider Transactions in Q2 2022 at X4 Pharmaceuticals, Inc (XFOR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,578
-0.87%
|
-
|
|
Jun 30
2022
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,641
-1.41%
|
-
|
|
Jun 24
2022
|
Derek M Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,166
-2.64%
|
-
|
|
Jun 24
2022
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
6,724
-1.03%
|
-
|
|
Jun 24
2022
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
856
-0.47%
|
-
|
|
Jun 24
2022
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,416
-2.81%
|
-
|
|
Jun 16
2022
|
Derek M Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,166
-2.57%
|
-
|
|
Jun 16
2022
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
856
-0.47%
|
-
|
|
Jun 16
2022
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
6,724
-1.02%
|
-
|
|
Jun 16
2022
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,416
-2.73%
|
-
|
|
Jun 06
2022
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+50.0%
|
-
|
|
Jun 06
2022
|
William Aliski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+50.0%
|
-
|
|
Jun 06
2022
|
Murray Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+50.0%
|
-
|
|
Jun 06
2022
|
Francoise De Craecker Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+50.0%
|
-
|
|
Jun 06
2022
|
Michael S Wyzga Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+50.0%
|
-
|
|
Jun 06
2022
|
Alison Frances Lawton Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+50.0%
|
-
|
|
Jun 06
2022
|
Gary Bridger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+50.0%
|
-
|
|
Jun 03
2022
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
6,292
-0.94%
|
$6,292
$1.21 P/Share
|